EDGAR Filing Documents for 0001193125-21-054696

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-21-054696

Filing Date

2021-02-24

Accepted

2021-02-24 16:27:31

Documents

Effectiveness Date

2021-02-24

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	d134950ds8.htm	S-8	52089
2	EX-5.1	d134950dex51.htm	EX-5.1	12940
3	EX-23.1	d134950dex231.htm	EX-23.1	1925
4	GRAPHIC	g134950g16i72.jpg	GRAPHIC	4961
5	GRAPHIC	g134950g84p59.jpg	GRAPHIC	6700
	Complete submission text file	0001193125-21-054696.txt		84321

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-253452 | Film No.: 21673682
SIC: 2834 Pharmaceutical Preparations